‘Fit and healthy woman' left paralysed at 44 after GP dismissed her ‘work stress' headaches
Alicja Faryniarz, 44, said she knew something "wasn't right" but her symptoms were constantly dismissed by doctors as migraines or sinus problems.
12
12
12
12
The accountant began suffering from severe headaches during her 20s which led to fainting episodes and extreme fatigue.
However each time she went to her GP, she says they "brushed it aside" and prescribed her with painkillers despite her suffering "intense pain".
But in September last year, she suffered a stroke while playing a tennis match.
Alicja collapsed on the court and was taken to hospital where she was diagnosed with brain arteriovenous malformation (AVM) - an ultra rare brain disease.
AVM affects less than 1 per cent of Brits and is caused by tangled blood vessels that create irregular connections between arteries and veins in the brain.
They are usually congenital - present from birth - but they can form later in life and people with the disease rarely show symptoms, according to the NHS.
Alicja had a three-inch AVM which ruptured and paralysed the right side of her body and also left her in a coma for three days.
She is now warning of the "hidden" dangers of the rare condition which she had no idea she was born with.
Alicja, from Cobham, Surrey, said: "My life ended on the day I had the stroke and I'm still trying to get it back.
"I've had to give up my life as I can no longer enjoy the things I loved like cycling, running, dancing, walking my dog, the list goes on.
"If I was given a CT scan instead of doctors brushing it aside, I believe they would have found it and none of this would have happened. I'm no longer the same person."
Alicja believes her AVM rupture was triggered by stress at work which weakened her blood vessels.
She also believes a blood donation she made the week before could have made her blood thicker, with exercise then putting extra stress on her veins.
She said: "I had a lot of plates spinning and life was very overwhelming at times.
12
12
"I would have these severe headaches where I would have to pause work and lie down for a moment and take some time until it passed."
Alicja first noticed symptoms in her early 20s, suffering with severe headaches and fainting episodes.
She said doctors gave her painkillers to deal with the "horrific pain" and she continued with her daily life, still exercising regularly and going to work.
But following her move to the UK from Poland in 2004 her symptoms got worse as she began suffering with more frequent headaches and extreme fatigue.
In 2021 - during the Covid-19 pandemic - she had her first extreme fainting episode, collapsing in her bathroom and suffering a black eye and concussion.
Alicja said: "I had collapsed and hit my head on the bathroom tiles.
"An ambulance was called but they only arrived the next day and as I had Covid at the time they wouldn't take me to the hospital."
Alicja believes that if she was taken to the hospital and had a brain scan performed, they would have found the AVM and her life would still be normal.
'I thought I was dying'
The 44-year-old went on to suffer three more fainting episodes until her stroke on September 3 last year.
Recalling the day, Alicja said: "I had worked from home and had travelled to Esher Tennis Club for an end of summer competition.
"The past weekend I had been on a 115km bike ride and went on a walk with friends and to be honest I wasn't feeling to well but I had gotten used to it.
"I played the first game fine, but then during the second match I hadn't played for very long when my vision went blurry and I had a really intense headache.
"I remember collapsing to the floor not being able to move or speak and being in agony - I was terrified and thought I was dying."
Alicja said an ambulance didn't arrive for two hours before she was transported to St Peter's Hospital in Chertsey where she was put into an induced coma.
What is an arteriovenous malformation (AVM)?
An AVM is a tangle of blood vessels in thebrain or on the brain surface.
This causes blood to bypass the usual network of vessels and flows directly from arteries to veins.
Symptoms may vary depending on the size and location of the AVM
within the brain.
While AVMs commonly cause no symptoms at all, they can lead to seizures, headaches, speech disturbances and visual disturbances.
Sometimes a brain AVM is found after the blood vessels burst and bleed, known as a haemorrhage.
The cause of brain AVMs isn't clear. Most people who have them are born with them, but they can form later in life.
They are typically discovered between the ages of 20 and 40.
Source: NHS
She was then transported to London's St George's Hospital and placed on the ICU unit, waking up three days later on September 6.
Alicja said: "When I woke up I was unable to move the right side of my body and I couldn't speak.
"I had to physically pick up my right and and leg with my right hand just to move it.
"Half my body was gone, like it never existed, like someone had just taken it away.
"It took me two weeks just to be able to move my middle finger a little."
12
12
12
12
Alicja stayed at St George's hospital until September 22, when she was moved to Woking Community Hospital for just over a month.
Now a year on Alicja can talk, move her right arm, but she can no longer walk without the aid of a walking stick or wheelchair.
She added: "If you know or think something is wrong make sure you get it checked out.
"I'm sharing my story as I want to spread awareness that it could happen to anybody."
What are the symptoms of stroke?
The FAST method – which stands for Face, Arms, Speech, Time – is the easiest way to remember the most common symptoms of stroke:
F = Face drooping - if one side of a person's face is dropped or numb then ask them to smile, if it's uneven then you should seek help.
A = Arm weakness - if one arm is weak or numb then you should ask the person to raise both arms. If one arm drifts downwards then you might need to get help
S = Speech difficulty - if a person's speech is slurred then this could be a sign of a stroke
T = Time to call 999 - if a person has the signs above then you need to call 999 in the UK or 911 in the US for emergency care.
Other symptoms include:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 minutes ago
- The Independent
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
The Sun
2 minutes ago
- The Sun
Man, 45, died ‘taking de-worming drug for animals after seeing fake claims online it could cure cancer'
A MAN died after taking a de-worming drug for animals as he believed it would cure cancer, an inquest heard. Lee Redpath, 45, was rushed to hospital with signs of liver failure after dosing himself with an anti-parasitic drug called fenbendazole across a three-week period. 7 7 7 He tragically died in Addenbrooke's Hospital, in Cambridge, on April 29. Lee had ordered the drug, believing it to be safe, from a supplier in Ukraine. The 45-year-old saw fake social media posts which claimed fenbendazole could be a cancer cure - despite it being banned for human use. It's designed to be used against a number of gastrointestinal parasites in animals including giardia, roundworms, hookworms, whipworms, tapeworms and pinworms. However, even A-list celebrities have promoted the drug for humans, including actor Mel Gibson. He told Joe Rogan earlier this year how three of his friends were cured of stage four cancer after taking it with the anti-parasitic Ivermectin. The inquest, held in Lawrence Court, Huntingdon, Cambs, heard how Lee believed the de-wormer could prevent cancer. His long-term partner Lauren Laul gave evidence at the inquest. She told how her boyfriend believed it was safe to use and popular in the States. 'He saw it online, thought it was safe, people in America are using it," said Lauren. 'He didn't have medical assistance taking it so I think some sort of warning should be made. 'I am seeing it advertised online and people can get it themselves like Lee did and unknowingly be killing themselves because they didn't have all the information.' Lauren also suggested Lee may have been taking them for as long as two years before his death. Dr Gwilym Webb, a consultant hepatologist at Addenbrooke's warned fenbendazole had 'no proven benefit for preventing or treating cancer in humans.' 7 7 7 He told the inquest Lee was not eligible for a liver transplant due to alcohol misuse in the three months before. But a post-mortem concluded Lee's liver failure was due to the fenbendazole. Assistant coroner for Cambridgeshire and Peterborough, Caroline Jones, concluded Lee died of liver and renal failure due to fenbendazole induced liver injury on a background of alcohol related cirrhosis. 'I was satisfied as to the toxic effects of fenbendazole and that it was this that was the primary cause of the injury," she told the inquest. 'It is a potent anti-worming treatment which was taken at far higher relative doses than had ever been envisaged and over a far longer time scale. 'During his admission he advised doctors that he had been taking the drug fenbendazole, which he purchased online from a supplier in the Ukraine after seeing videos about its supposed anti-cancer properties. 'It was thought likely fenbendazole was the primary cause of the acute injury. Lee's conditions deteriorated despite treatment but he was not a candidate for transplant. 'He improved briefly but on April 27 his condition worsened, it was recognised Lee's organs were failing and he passed away at 6.06 pm on April 29. 'While Lee may have taken fenbendazole with good intentions to improve his health, it constituted a deliberate act with the unintended consequence of his death.' Lauren urged the coroner to write a prevention of future deaths report, but Miss Jones denied her request. The coroner said there was not "sufficient evidence", although she was "concerned" about people buying the drug online. Lee's death was recorded as misadventure. 7
The Independent
32 minutes ago
- The Independent
Patients whose lives were ruined after being ‘needlessly given cancer drug for years' sue NHS trust
More than 20 patients who say their quality of life was wrecked when they were needlessly given a highly toxic cancer drug are suing the NHS trust involved. Some people were prescribed temozolomide – which should normally be used for only six months – for more than a decade during treatment by the University Hospitals Coventry and Warwickshire NHS Trust. They say the overprescribing left them with side-effects including secondary cancers and crippling fatigue. Earlier this year the Care Quality Commission was looking into at least 14 cases, but lawyers say more are emerging all the time. An investigation by lawyers Brabners found that, over the past two decades, numerous patients with brain and spinal tumours under the care of Professor Ian Brown were routinely exposed to prolonged and in some cases 'unnecessary' use of the chemotherapy drug, which has severe side-effects including extreme fatigue, confusion, sickness and seizures. The time periods temozolomide was given for allegedly ran contrary to medical and scientific guidelines. Standard NHS procedure is to use the drug over six months, and the drug manufacturer advises it be used for up to 12 months. One man said he was prescribed it for nearly two years longer than necessary, suffering extreme fatigue and low mood as a result. A woman in her twenties said she was misdiagnosed with cancer, receiving the drug needlessly for about eight years. Some patients are now having treatment for secondary cancers allegedly linked to overuse of temozolomide, the lawyers claim. Others claimed its prolonged use left them unable to pursue career ambitions and normal day-to-day activities because the chemotherapy was debilitating, with a long recovery time. Some reported loss of fertility or abnormal blood test results. The legal team says data shows that the trust's spending on the drug of £3.6m from 2009 to 2024 is 10 times that of other NHS oncology departments. The lawyers are now calling for an extended patient safety review and independent investigation, focusing in particular on treatment received by patients under Prof Brown dating back to 2006. The trust has been conducting an internal patient safety review, covering 2017 to 2023, when Prof Brown retired. A patient who identified only as Michael received an extra 22 cycles of temozolomide at the trust, despite his scans being stable. Prof Brown was not present during consultations, and Michael said he was always seen by a clinical nurse specialist. After suffering extreme fatigue and low mood, he learnt through news reports of mistreatment –not from the trust – that he should not have remained on treatment for so long, according to his lawyers. Another patient, identified only as Becky, says she received at least 100 cycles of the drug unnecessarily after being misdiagnosed with a brain tumour. Fiona Tinsley, head of medical negligence at Brabners, said: 'The extent of this scandal, and the physical and mental impact it has had on Prof Brown's patients cannot be underestimated.' She added: 'We believe there are many more patients out there who haven't yet come forward and some who may have sadly passed away. 'While we welcome the ongoing investigations being undertaken by the General Medical Council and Royal College of Physicians, we believe a full independent inquiry is necessary – including an extension of the trust's own review back to 2006 – not only to ensure justice for victims, but that processes are put in place to better identify and prevent such failings happening again.' A spokesperson for the trust told The Independent: 'We have comprehensively reviewed and spoken to all individuals who were receiving temozolomide (TMZ) treatment at the end of 2023 to ensure appropriate support and care plans are in place. 'A glioblastoma is an aggressive brain tumour with fewer than two per cent of patients surviving longer than 10 years. This is an extremely complex condition and all modes of treatment – surgery, chemotherapy and radiotherapy – carry the risk of complications and side-effects. 'National Institute for Health and Care Excellence (Nice) guidelines recognise that clinicians can exercise professional judgment appropriate to individual circumstances when offering treatment to patients. 'We have commissioned the Royal College of Physicians to conduct an independent review of a representative cohort of patients who received greater than 12 cycles of adjuvant TMZ between 2017 and 2023. 'As this process is ongoing, it would be inappropriate to comment further at this stage." It's understood that CQC inspectors have been in touch with the trust to understand the details, and seek assurances that patients are not at risk. The regulator will be reviewing more information to judge whether it needs to be involved.
